{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:41:03Z","timestamp":1781649663351,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.semnephrol.2009.01.002","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T08:15:24Z","timestamp":1239783324000},"page":"97-104","source":"Crossref","is-referenced-by-count":17,"title":["Chronic Kidney Disease\/Bone and Mineral Metabolism: The Imperfect Storm"],"prefix":"10.1016","volume":"29","author":[{"given":"Mark E.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2009.01.002_bib1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: a growing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidiol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1359\/jbmr.080420","article-title":"Vitamin D and health: from mice and man","volume":"23","author":"Bouillon","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/ki.2008.321","article-title":"Bone mass gain after parathyroidectomy","volume":"74","author":"Pasch","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib10","first-page":"135","article-title":"Adynamic bone disease\u2014bone and beyond","volume":"3","author":"Brandenburg","year":"2008","journal-title":"Nephrol Dial Transplant Plus"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib16","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"27","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib17","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders of mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2215\/CJN.05161107","article-title":"Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis","volume":"3","author":"Ketteler","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ki.5001997","article-title":"A new era in phosphate binder therapy: what are the options?","volume":"70","author":"Salusky","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor -23-Klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"Razzaque","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.ki.5002651","article-title":"What does serum fibroblast growth factor 23 do in hemodialysis patients?","volume":"73","author":"Emmett","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib29","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2007060673","article-title":"Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD","volume":"19","author":"Isakova","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib31","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib32","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Guetierez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib33","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","article-title":"Fibroblast growth factor-23 is regulated by 1alpha, 25-dihrydoxyvitamin D","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","article-title":"Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients","volume":"73","author":"Urena-Torres","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: a disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib36","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.01520407","article-title":"Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism","volume":"2","author":"Felsenfeld","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1523-1755.2001.059003855.x","article-title":"p21 (WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth","volume":"59","author":"Dusso","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib38","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1681\/ASN.2007040406","article-title":"EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease","volume":"19","author":"Arcidiacono","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib40","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ki.5001595","article-title":"Pathogenic mechanisms for parathyroid hyperplasia","volume":"102","author":"Dusso","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib41","doi-asserted-by":"crossref","unstructured":"Arcidiacono MV, Cozzolino M, Spiegel N, Tokumoto M, Yang J, Lu Y, et al. Activator protein 2(alpha) mediates parathyroid TGF-{alpha} self-induction in secondary hyperparathyroidism. J Am Soc Nephrol. 2008 [accessed 2008 October 15]. Epub PMID 18579641.","DOI":"10.1681\/ASN.2007111216"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.ki.5002696","article-title":"Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?","volume":"73","author":"Schoppet","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2007070765","article-title":"Association of mild to moderate kidney dysfunction and coronary calcification","volume":"19","author":"Ix","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.ackd.2006.10.007","article-title":"Mechanisms of vascular calcification","volume":"14","author":"El-Abbadi","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib46","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.ki.5001996","article-title":"Novel insights into vascular calcification","volume":"70","author":"Ketteler","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators in vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.ki.5002738","article-title":"Metabolic acidosis and vascular calcification: using blueprints from bone to map a new venue for vascular research","volume":"73","author":"Al-Aly","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ki.5002646","article-title":"Metabolic acidosis inhibits soft tissue calcification in uremic rats","volume":"3","author":"Mendoza","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib51","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.2174\/092986707782794096","article-title":"Calcium sensing receptor activators: calcimimetics","volume":"14","author":"Harrington","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib52","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib53","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1093\/ndt\/gfn191","article-title":"Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet","volume":"23","author":"deFrancisco","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib54","doi-asserted-by":"crossref","unstructured":"Valle C, Rodriquez M, Santamaria R, Almaden Y, Rodriguez ME, Canadillas S, et al. Cinacalcet reduces the set point of the PTH-calcium curve. J Am Soc Nephrol. 2008 [accessed 2008 October 17]. Epub PMID 18632847.","DOI":"10.1681\/ASN.2007121320"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncpneph0821","article-title":"Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease","volume":"4","author":"Coyne","year":"2008","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ncpneph0832","article-title":"Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease","volume":"4","author":"deFrancisco","year":"2008","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.002_bib58","unstructured":"Health Canada online. Sensipar R no longer indicated for chronic kidney disease patients (stages 3 and 4) not receiving dialysis. [accessed 2008 September 9]. Available from: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/medeff\/advisories-avis\/prof\/2007\/sensipar_hpc-cps_e.html."},{"key":"10.1016\/j.semnephrol.2009.01.002_bib59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchoi","year":"2009","journal-title":"Am J Kidney Dis"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929509000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929509000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T04:40:01Z","timestamp":1633322401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929509000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0270929509000035"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2009.01.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}